Meitav Dash Investments Ltd. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 97.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 702 shares of the medical equipment provider’s stock after selling 32,379 shares during the period. Meitav Dash Investments Ltd.’s holdings in Intuitive Surgical were worth $415,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Parametric Portfolio Associates LLC raised its holdings in shares of Intuitive Surgical by 5.6% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 337,240 shares of the medical equipment provider’s stock worth $182,086,000 after buying an additional 17,987 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $81,000. Canal Capital Management LLC increased its position in shares of Intuitive Surgical by 6.2% during the 4th quarter. Canal Capital Management LLC now owns 1,512 shares of the medical equipment provider’s stock worth $894,000 after purchasing an additional 88 shares in the last quarter. AE Wealth Management LLC increased its position in shares of Intuitive Surgical by 7.6% during the 3rd quarter. AE Wealth Management LLC now owns 1,310 shares of the medical equipment provider’s stock worth $707,000 after purchasing an additional 92 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in Intuitive Surgical by 222.5% during the 4th quarter. Acadian Asset Management LLC now owns 1,948 shares of the medical equipment provider’s stock valued at $1,151,000 after purchasing an additional 1,344 shares during the last quarter. Institutional investors and hedge funds own 81.72% of the company’s stock.
A number of equities analysts have commented on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $692.00 price target on the stock in a research report on Wednesday, January 22nd. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $665.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $690.00 target price (up previously from $620.00) on shares of Intuitive Surgical in a research note on Friday, January 10th. Canaccord Genuity reissued a “buy” rating on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Goldman Sachs Group started coverage on Intuitive Surgical in a research report on Wednesday, February 12th. They set a “buy” rating and a $725.00 price target on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $627.14.
In other news, Director Alan J. Levy sold 1,950 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $575.00, for a total transaction of $1,121,250.00. Following the transaction, the director now directly owns 9,527 shares of the company’s stock, valued at $5,478,025. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Jamie Samath sold 1,492 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $600.00, for a total transaction of $895,200.00. Following the completion of the transaction, the senior vice president now directly owns 540 shares of the company’s stock, valued at approximately $324,000. The disclosure for this sale can be found here. Insiders have sold a total of 32,107 shares of company stock valued at $18,544,904 over the last 90 days. Corporate insiders own 1.70% of the company’s stock.
ISRG stock traded down $14.91 during trading on Thursday, hitting $544.62. The company had a trading volume of 773,446 shares, compared to its average volume of 612,670. The firm has a 50-day moving average price of $590.65 and a 200-day moving average price of $557.95. Intuitive Surgical, Inc. has a 12 month low of $455.15 and a 12 month high of $619.00. The stock has a market cap of $64.89 billion, a price-to-earnings ratio of 47.15, a PEG ratio of 4.60 and a beta of 1.10.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 23rd. The medical equipment provider reported $3.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.10. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. Intuitive Surgical had a return on equity of 18.16% and a net margin of 30.80%. The firm’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.96 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 10.52 earnings per share for the current fiscal year.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
See Also: What is the Nikkei 225 index?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.